Moreover, lncRNA 91H demonstrated oncogenic activity in vitro and in vivo; specifically, 91H promoted the aggressive phenotype of BC cells via regulating the expression of H19/IGF2 imprinting locus by masking the methylation site on the imprinting control center and the H19 promoter [236]. The gene discussed is IGF2; the disease is breast cancer.